Healthy Growth In Latin American Pharma Market

7 July 1996

In Latin America, the consumer health care market, including prescription pharmaceuticals, over-the-counter medicines and consumption of self-medication products, totalled $17.37 billion in 1995, representing an increase of 86.6% over 1991, according to a new report entitled Consumer Healthcare in Latin America, from international market analysts Euromonitor.

As a percentage of total consumer expenditure, health care product purchases jumped from 1.2% to 1.9% during the survey period. Euromonitor attributes this impressive market growth to price deregulation, lower import tariffs, higher-profile retail distribution and increased marketing of self-medication products throughout the region.

Brazil dominates the regional market, accounting for more than 42% of Latin American health care spending. Between 1991 and 1995, both Brazilian and Colombian health care markets experienced phenomenal growth rates of 145.7% and 139.1% respectively, the report shows.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight